Derek Wallace Email and Phone Number
Derek Wallace work email
- Valid
- Valid
Derek Wallace personal email
- Valid
With 17 years of experience in vaccine research, I currently serve as the President of Takeda’s Vaccine Business Unit. I joined Takeda in September of 2013 and previously served as Vice President and Head of the Global Dengue Program, where I led the global team in the development and commercialization of our dengue vaccine. I obtained my Bachelor of Medicine and Bachelor of Surgery (MBBS) from The University of Queensland in 1997 and worked clinically for 5 years in Australia and the United Kingdom before joining Merck KgGa. During my time with Merck, I obtained a Diploma of Pharmaceutical Medicine from the Royal College of Physicians in the UK. Following Merck, I transitioned to the Novartis Transplant Business Unit where I worked in medical affairs and clinical development in the United Kingdom for two years. After Novartis, I continued my professional career at Sanofi Pasteur, where I received my Diploma of Vaccinology from Institute Pasteur, Paris in 2008. I was the clinical team leader for key studies of Sanofi's dengue vaccine candidate, and was responsible for the study design, conduct and interpretation of results of these studies. Outside of work, I enjoy gardening, traveling and good food with good company. I was born in Papua New Guinea, grew up in Brisbane, Australia and lived in the UK, France, Singapore and Switzerland. I currently live in Boston, USA.All views expressed are my own.
-
Vp And Global Dengue Program Head, Takeda Vaccine Business UnitTakeda Dec 2016 - PresentTokyo, JpLead the Global Program Team in the development of Takeda's Tetravalent Dengue Vaccine -
Global Programme Medical DirectorTakeda Vaccines Sep 2013 - PresentResponsible for the global clinical development of Takeda's Tetravalent Live Attenuated Dengue Vaccine and EV71 Vaccine candidates.
-
Director, Clinical DevelopmentSanofi Pasteur Nov 2007 - Sep 2013Paris, France, FrJanuary 2009 - September 2013Clinical team leader for key studies of Sanofi's dengue vaccine candidate, including a Phase 2b efficacy study, the first Phase 3 study and a Phase 3 efficacy study. Responsible for study design, conduct and interpretation of results.November 2007 to December 2008Clinical team leader for Influenza studies and preparations for first-in-man studies of vaccine candidates for Malaria and Meningitis B. -
Medical ManagerNovartis Mar 2005 - 2007Basel, Baselstadt, ChResponsible for Medical Affairs and Clinical Development in the United Kingdom at Novartis Transplant Business Unit -
Senior Medical AdvisorMerck Group Jan 2003 - Mar 2005Darmstadt, DeMedical Affairs for cardiology and women's health products
Derek Wallace Skills
Derek Wallace Education Details
-
The University Of QueenslandBachelor Of Surgery (Mbbs) -
Institute PasteurDiploma Of Vaccinology -
University Of Wales, CardiffDiploma Of Pharmaceutical Medicine
Frequently Asked Questions about Derek Wallace
What company does Derek Wallace work for?
Derek Wallace works for Takeda
What is Derek Wallace's role at the current company?
Derek Wallace's current role is President, Global Vaccine Business Unit, Takeda Pharmaceuticals.
What is Derek Wallace's email address?
Derek Wallace's email address is de****@****ail.com
What schools did Derek Wallace attend?
Derek Wallace attended The University Of Queensland, Institute Pasteur, University Of Wales, Cardiff.
What skills is Derek Wallace known for?
Derek Wallace has skills like Clinical Development, Vaccines, Clinical Trials, Pharmaceutical Industry, Clinical Research, Infectious Diseases, Clinical Study Design.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial